Webinar: Novel strategies to dissect functional heterogeneity towards designing personalized combination treatment strategies

Register Now

Join us for a Live Webinar.

Date: Thursday, September 24, 2020 

Time: 9:00 am - 10:00 am USA Central Daylight Time (CDT), 4:00 pm - 5:00 pm Central European Time (CET)

Speakers: Sahil Seth, TRACTION Group, MD Anderson Cancer Center and Paul Diehl, Ph.D., COO, Cellecta

Sahil Seth MD Anderson     


Adaptive drug-resistance mechanisms allow human tumors to evade treatment through selection and expansion of treatment-resistant clones. Studying clonal evolution using lineage tracing, allows high-resolution tracking of tumorigenic clones in vivo and in vitro, and establishing clonal replica tumors (CRTs). We used these systems to study characteristics of chemo-resistance and metastasis in pancreatic and triple-negative breast cancer (TNBC) tumors, respectively. We uncovered a multitude of functionally heterogeneous sub-populations of cells with differential degrees of drug sensitivity.


  • DNA barcode-based lineage tracing reveals in vivo and in vitro clones are maintained by a common set of clones, aiding in creating clonal replica tumors (CRTs)
  • CRTs aid in unmasking functional heterogeneity in tumors, in response to therapeutics
  • Evidence of a pre-existing chemo-resistant population in clonal replica

A brief overview of Cellecta technologies and a live Q&A session will follow the presentation.

Upon registering, you will also receive a link to a recent publication detailing the team's work.

Register Now


Also in Events, Conferences, Meetings

Webinar: CRISPR/Cas9 Screens to Investigate Mechanisms of Cancer Drug Resistance

August 27, 2020, Live Webinar

Read More
Cell Symposia: The Conceptual Power of Single-Cell Biology

April 19-21, 2020, Mission Bay Conference Center at UCSF 
Read More
2020 American Association of Cancer Research (AACR) Annual Meeting

April 24-29, 2020, San Diego Convention Center, San Diego, CA

Read More